Correlation Between Duopharma Biotech and Sunway Construction

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and Sunway Construction at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and Sunway Construction into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and Sunway Construction Group, you can compare the effects of market volatilities on Duopharma Biotech and Sunway Construction and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of Sunway Construction. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and Sunway Construction.

Diversification Opportunities for Duopharma Biotech and Sunway Construction

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Duopharma and Sunway is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and Sunway Construction Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunway Construction and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with Sunway Construction. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunway Construction has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and Sunway Construction go up and down completely randomly.

Pair Corralation between Duopharma Biotech and Sunway Construction

Assuming the 90 days trading horizon Duopharma Biotech Bhd is expected to under-perform the Sunway Construction. But the stock apears to be less risky and, when comparing its historical volatility, Duopharma Biotech Bhd is 1.48 times less risky than Sunway Construction. The stock trades about 0.0 of its potential returns per unit of risk. The Sunway Construction Group is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  159.00  in Sunway Construction Group on August 31, 2024 and sell it today you would earn a total of  271.00  from holding Sunway Construction Group or generate 170.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  Sunway Construction Group

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Sunway Construction 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sunway Construction Group are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Sunway Construction may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Duopharma Biotech and Sunway Construction Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and Sunway Construction

The main advantage of trading using opposite Duopharma Biotech and Sunway Construction positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, Sunway Construction can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunway Construction will offset losses from the drop in Sunway Construction's long position.
The idea behind Duopharma Biotech Bhd and Sunway Construction Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities